EN
HI
Haleos Labs Chart
Haleos Labs Share Key Metrics
Volume
474.00
Market Cap
389.19 CR
LTQ@LTP
65@1287.30
ATP
1284.47
Var Margin
25 %
Circuit Range
1141.4-1395
Delivery %
88.81 %
Value
6.09 L
ASM/GSM
No
Market Lot
1
Summary
At 10 Apr, 2026 | 15:31, Haleos Labs share price stands at ₹1287.3, showing a 19.10% 1.51 for the day. The stock’s intraday movement has stayed between ₹1263.00 and ₹1299.30, while on a 52-week basis it has fluctuated from ₹1067.00 to ₹1680.00.
In terms of trading activity, Haleos Labs has recorded a volume of 474 shares, with a market capitalisation of ₹3023287. The stock’s Average Traded Price (ATP) stands at ₹128447, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 65,128730. The stock operates within a circuit range of ₹1141.4-1395, with a Value of ₹6.09 L. The Delivery Percentage for the day is 88.81%. Additionally, Haleos Labs currently falls under the No framework, and trades with a market lot size of 1.
Haleos Labs Fundamentals
View MoreP/E Ratio
19.32
P/B Ratio
1.8
Div. Yield
0.12
Sector P/E
62.26
Sector P/B
3.36
Sec. Div. Yield
0.58
Haleos Labs Resistance and Support
Pivot 1276.2
Resistance
First Resistance
1290.4
Second Resistance
1312.6
Third Resistance
1326.8
Support
First Support
1254
Second Support
1239.8
Third Support
1217.6
Haleos Labs Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-10 | Quarterly Results |
| 2025-08-11 | Quarterly Results & A.G.M. |
| 2025-05-29 | Audited Results & Dividend |
Haleos Labs News
Haleos Labs Ltd - 540679 - Annual Confirmation (Reclassification)
Haleos Labs received annual confirmation from erstwhile promoters Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri, verifying their continued compliance with SEBI's reclassification norms. This confirms they hold less than 10% voting rights and no control, adhering to Regulation 31A post-2022 reclassification.
Apr 08 2026 11:04:00
Haleos Labs Ltd - 540679 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Haleos Labs initiated a postal ballot for an ordinary resolution concerning a ₹20 crore corporate guarantee to secure external commercial borrowing for its subsidiary, Mahi Drugs Private Limited. This related party transaction aims to support the subsidiary's business operations and funding needs.
Mar 30 2026 14:03:00
Read More
About Haleos Labs
NSE : 21551
BSE : 540679
ISIN : INE320X01016
Haleos Labs Management
| Name | Position |
|---|---|
| Mr. TVVSN Murthy | Managing Director |
| Mr. T V Praveen | Executive Director |
Haleos Labs FAQs
The Buying Price of Haleos Labs share is 1287.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Haleos Labs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Haleos Labs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Haleos Labs shares is 19.32. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Haleos Labs shares is 1.8. Useful to assess the stock's value relative to its book value.
To assess Haleos Labs’s valuation compare Sector P/E, P/B which are 62.26 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Haleos Labs is 389.19 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Haleos Labs share price is 1680.00 & 1067.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Haleos Labs belongs to the Healthcare sector.
